Tenax Therapeutics's total assets for Q2 2025 were $105.86M, a decrease of -5.53% from the previous quarter. TENX total liabilities were $2.53M for the fiscal quarter, a -8.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.